These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17876053)
1. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice. Van Roy M; Van Lint P; Van Laere I; Wielockx B; Wilson C; López-Otin C; Shapiro S; Libert C Mol Cancer Ther; 2007 Sep; 6(9):2563-71. PubMed ID: 17876053 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Wielockx B; Lannoy K; Shapiro SD; Itoh T; Itohara S; Vandekerckhove J; Libert C Nat Med; 2001 Nov; 7(11):1202-8. PubMed ID: 11689884 [TBL] [Abstract][Full Text] [Related]
3. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy. Van Roy M; Wielockx B; Baker A; Libert C Cancer Gene Ther; 2007 Apr; 14(4):372-9. PubMed ID: 17218947 [TBL] [Abstract][Full Text] [Related]
4. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Wright JL; Tai H; Wang R; Wang X; Churg A Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L125-33. PubMed ID: 16905636 [TBL] [Abstract][Full Text] [Related]
5. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice. Corbel M; Lanchou J; Germain N; Malledant Y; Boichot E; Lagente V Eur J Pharmacol; 2001 Aug; 426(1-2):113-21. PubMed ID: 11525779 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse. Grossetete M; Rosenberg GA J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790 [TBL] [Abstract][Full Text] [Related]
8. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper. Rucavado A; Escalante T; Teixeira CF; Fernándes CM; Diaz C; Gutiérrez JM Mediators Inflamm; 2002 Apr; 11(2):121-8. PubMed ID: 12061424 [TBL] [Abstract][Full Text] [Related]
9. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784 [TBL] [Abstract][Full Text] [Related]
10. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Walker EJ; Rosenberg GA Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539 [TBL] [Abstract][Full Text] [Related]
11. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line. Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458 [TBL] [Abstract][Full Text] [Related]
12. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. Lee SR; Tsuji K; Lee SR; Lo EH J Neurosci; 2004 Jan; 24(3):671-8. PubMed ID: 14736853 [TBL] [Abstract][Full Text] [Related]
13. Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. Bianchini F; D'Alessio S; Fibbi G; Del Rosso M; Calorini L Oncol Rep; 2006 Mar; 15(3):709-14. PubMed ID: 16465434 [TBL] [Abstract][Full Text] [Related]
14. Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis. Kremastiotis G; Handa I; Jackson C; George S; Johnson J Sci Rep; 2021 Nov; 11(1):23081. PubMed ID: 34848763 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Keck T; Balcom JH; Fernández-del Castillo C; Antoniu BA; Warshaw AL Gastroenterology; 2002 Jan; 122(1):188-201. PubMed ID: 11781293 [TBL] [Abstract][Full Text] [Related]
16. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. Li YY; Kadokami T; Wang P; McTiernan CF; Feldman AM Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H983-9. PubMed ID: 11834496 [TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978 [TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. Uchida M; Shima M; Shimoaka T; Fujieda A; Obara K; Suzuki H; Nagai Y; Ikeda T; Yamato H; Kawaguchi H J Cell Physiol; 2000 Nov; 185(2):207-14. PubMed ID: 11025442 [TBL] [Abstract][Full Text] [Related]
19. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Lee PP; Hwang JJ; Murphy G; Ip MM Endocrinology; 2000 Oct; 141(10):3764-73. PubMed ID: 11014232 [TBL] [Abstract][Full Text] [Related]
20. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles. Hrabia A; Socha JK; Sechman A Gen Comp Endocrinol; 2018 May; 260():32-40. PubMed ID: 29438675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]